A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Internal Medicine

• Publication date

  1991-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2796.1991.tb00304.xPMID 1995762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mortality and coronary events in two Italian MONICA areas: area Latina and area Brianza.

  2009cited by this paper
• Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.

  1989cited by this paper
• Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46).

  1989cited by this paper
• Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia.

  1988cited by this paper
• Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice.

  1988cited by this paper
• Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.

  1988cited by this paper
• Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred.

  1988cited by this paper
• Characterization of genetic markers in the 3' end of the apo B gene and their use in family and population studies.

  1988cited by this paper
• Low plasma cholesterol levels caused by a short deletion in the apolipoprotein B gene.

  1988cited by this paper
• Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.

  1988cited by this paper
• Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

  1987cited by this paper
• Increased catabolism of VLDL-apolipoprotein B and synthesis of bile acids in a case of hypobetalipoproteinemia.

  1987cited by this paper
• Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease.

  1986cited by this paper
• Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.

  1986cited by this paper
• Epidemiology of Lipids and Lipoproteins as a Guide to the Detection of Mutants

  1986cited by this paper
• Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels.

  1986cited by this paper
• Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

  1981cited by this paper
• Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

  1981cited by this paper
• Epileptogenic activity of sodium-folate and the blood-brain barrier in the rat.

  1973cited by this paper
• Familial hypo- -lipoproteinaemia.

  1972cited by this paper
• Bassen-Kornzweig Syndrome: Deficiency of Serum β-Lipoprotein: A Neuromuscular Disorder Resembling Friedreich's Ataxia, Associated with Steatorrhea, Acanthocytosis, Retinitis Pigmentosa, and a Disorder of Lipid Metabolism

  1963cited by this paper
• Analysis of the Apolipoprotein B Gene and Messenger Ribonucleic Acid in Abetalipoproteinemia

  year unknowncited by this paper

• ANGPTL3 deficiency impairs lipoprotein production and produces adaptive changes in hepatic lipid metabolism

  2024cites this paper
• How ANGPTL3 Inhibition Will Help Our Clinical Practice?

  2023cites this paper
• Angiopoietin-like 3 inhibition and the liver: less is more?

  2023cites this paper
• ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis

  2022cites this paper
• Angiopoietin-like 3: An important protein in regulating lipoprotein levels.

  2022cites this paper
• Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia

  2021cites this paper
• Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.

  2021cites this paper
• Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions.

  2020cites this paper
• New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk?

  2018cites this paper
• Threshold Effects of Circulating Angiopoietin‐Like 3 Levels on Plasma Lipoproteins

  2017cites this paper
• Angiopoietin-like 3 in lipoprotein metabolism

  2017cites this paper
• Update on Primary Hypobetalipoproteinemia

  2014influential citation
• Recent developments in the genetics of LDL deficiency

  2013cites this paper
• Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.

  2012cites this paper
• Replication of linkage of familial hypobetalipoproteinemia to chromosome 3p in six kindreds.

  2002cites this paper
• Rat liver responsiveness to gluconeogenic substrates during insulin-induced hypoglycemia.

  2001cites this paper
• Two novel quantitative trait loci on mouse chromosomes 6 and 4 independently and synergistically regulate plasma apoB levels.

  2001cites this paper
• Preoperative feeding does not reverse postoperative insulin resistance in skeletal muscle in the rat.

  2000cites this paper
• In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.

  2000cites this paper
• Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22.

  2000cites this paper
• Diabetes mellitus in a new kindred with familial hypobetalipoproteinemia and an apolipoprotein B truncation (apoB-55).

  1998cites this paper
• Skeletal muscle insulin resistance after trauma: insulin signaling and glucose transport.

  1998cites this paper
• Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families.

  1998cites this paper
• Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoproteinemic kindred without any ApoB truncation.

  1997cites this paper
• Organ loci of catabolism of short truncations of apoB.

  1997cites this paper
• A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: genetic and metabolic studies.

  1996cites this paper
• The genetic basis of primary disorders of intestinal fat transport.

  1996cites this paper
• Familial hypobetalipoproteinemia associated with hypothyroidism.

  1995cites this paper
• Lexikon der Syndrome und Fehlbildungen

  1995cites this paper
• Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2).

  1994cites this paper
• Variable expression of familial heterozygous hypobetalipoproteinemia: transient malabsorption during infancy.

  1994cites this paper
• Relationship between plasma insulin and triglyceride concentrations in hypertriglyceridaemic donkeys.

  1994cites this paper
• [Classification of dyslipoproteinemias of genetic origin].

  1993cites this paper
• Effects of Pyrazinoylguanidine on the Glucose‐Fatty Acid Cycle in Normal Subjects and Patients with Non‐Insulin‐Dependent Diabetes Mellitus

  1993cites this paper
• The severity of obstructive sleep apnoea is associated with insulin resistance

  1993cites this paper
• Exercise endurance in rats: roles of type I and II corticosteroid receptors.

  1993cites this paper
• Familial hypobetalipoproteinemia.

  1993cites this paper
• Apolipoprotein B gene mutations affecting cholesterol levels

  1992cites this paper
• Hypobetalipoproteinaemia and truncated forms of human apolipoprotein B.

  1992cites this paper